CECILE ALANIO

Cécile is MD in Medical Biology (Immunology), PhD in Immunology, and a former PostDoc in Labex Milieu Interieur and in the Wherry lab at UPenn. She is the Deputy Director of the Clinical Immunology Laboratory at Institut Curie, where she helps coordinating the immunomonitoring of cancer patients. During her postdoc at UPenn, she worked on samples from COVID patients, as well as PDAC, glioblastoma, lymphoma, and CART cancer patients with a translational approach. She is now a Parker Bridge Scholar in the independent phase as a Scientist in the U932 (Amigorena team) at Institut Curie, Paris, France. Her group (T Cell Inspection, TCI) studies T cell biology in human health and disease. Her focus is on solid tumors and CAR T cells profiling.